ESR1 and breast carcinoma: By AE (any event)-free survival analysis of ER+/HER2-type breast cancer in bc-GenExMiner v4.3 [27], high MAFG-AS1 expression was found to be significantly associated with poor survival (Supplementary Figure 1C).